Response to Letter to the Editor 'Serum irisin concentration in patients with bladder cancer'

Int Urol Nephrol. 2022 Jun;54(6):1247-1248. doi: 10.1007/s11255-022-03215-3. Epub 2022 Apr 20.

Authors

Kerem Taken¹, Rahmi Aslan¹, Recep Eryilmaz¹, Hamit Hakan Alp², Zübeyir Huyut², Muhammet İrfan Dönmez³

Affiliations

¹ Department of Urology, Faculty of Medicine, Van Yuzuncu Yıl University, 65080, Van, Turkey.
² Department of Medical Biochemistry, Faculty of Medicine, Van Yuzuncu Yıl University, 65080, Van, Turkey.
³ Department of Urology, İstanbul University İstanbul Faculty of Medicine, İstanbul Tıp Fakültesi Cerrahi Monoblok, Üroloji Anabilim Dalı, Fatih, 34093, İstanbul, Türkiye. m_irfan83@yahoo.com.

PMID: 35441909
DOI: 10.1007/s11255-022-03215-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Fibronectins* / blood
Humans
Urinary Bladder Neoplasms*

Substances

Fibronectins